Sangamo Therapeutics (SGMO) Misses Q4 EPS by 10c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Total operating expenses: 22.03M
Today's EPS Names:
RCBC, GASS, YSG, More
Financial Fact:
Total operating expenses: 22.03M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q4 EPS of ($0.11), $0.10 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $14.23 million versus the consensus estimate of $33.18 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on Eos Energy Enterprises (EOSE) amid 10% gain: 'we view the collaboration with Google as a positive step for EOSE'
- Factory Orders (Jul) 0.9% vs 0.7% Expected
- Pegmatite One Confirms 100% Interest in Golden Scheelite Tungsten Project, Humboldt County, Nevada
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
